Incentivizing and Supporting Innovation in Kidney Care
Individuals living with kidney disease, especially kidney failure, have not experienced the same level of medical innovation that others living with conditions like cardiac disease or cancer have been able to access during the last 30 years. The relative stagnant reimbursement system coupled with the lack of a long-term pathway for sustaining innovative treatment options has led to this unacceptable situation.
KCP supports efforts from the administration, such as Advancing Kidney Health and KidneyX, that encourage innovation, as well as policies that ensure sufficient reimbursement through the Medicare ESRD program.
However, to support long-term innovation, the ESRD prospective payment system (PPS) itself must be reexamined to ensure policies that promote and foster innovations in care delivery. Without a sustainable system that encourages appropriate reimbursement, individuals with kidney diseases will be left behind yet again.
The work HHS and CMS have done to remove barriers to adopting innovative products and services for kidney care is an important starting point to incentivize innovation and innovative treatment options. Fostering innovation in kidney care generally is also central to the Administration’s goals of reducing inequities in health care.
KCP remains committed to working with CMS to foster innovation in technology, treatment, and medications through updates to current payment policy.
Comment Letters & Resources:
- KCP Response to CMS Request for Information on Health and Safety Requirements for Transplant Programs, Organ Procurement Organizations, and End-Stage Renal Disease Facilities (January 28, 2022)
- Comments on the CY 2022 End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) Proposed Rule (August 26, 2021)
- Comments on the CY 2021 End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) Proposed Rule (September 3, 2020)
- CY 2020 End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) Proposed Rule (September 11, 2019)